Aura Biosciences, Inc. Public Float
Aura Biosciences, Inc. (AURA) had Public Float of $321.00 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $321.00M.
- 2024-06-30: Entity Public Float $191.70M.
- 2023-06-30: Entity Public Float $224.60M.
- 2022-06-30: Entity Public Float $280.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $321.00M 10-K · filed 2026-03-30 |
| 2024-06-30 | $191.70M 10-K · filed 2025-03-24 |
| 2023-06-30 | $224.60M 10-K/A · filed 2024-06-14 |
| 2022-06-30 | $280.10M 10-K · filed 2023-03-15 |
| 2021-06-30 | $0.00 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |